Benzinga | Jan 3, 2022 07:04AM EST

Anebulo Pharma Announces Initiation of Phase 2 Clinical Study Evaluating ANEB-001 for the Treatment of Acute Cannabinoid Intoxication

Affirms expectations for initial topline results in 1H 2022